Navigation Links
Huifeng Bio-Pharmaceutical (HFGB) Announces 2007 Full Year Results
Date:3/31/2008

XI'AN, China, March 31 /Xinhua-PRNewswire-FirstCall/ -- Huifeng Bio- Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), a developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, is pleased to announce its audited financial results for the year ended December 31, 2007.

Full Year 2007 Highlights:

The following is a summary of our financial results for the full year ended Dec. 31, 2007.

12 Months Ended 12 Months Ended Growth

In US Dollars December 31,2007 December 31,2006 %

Net Revenue $6,571,531 $3,076,779 114%

Gross Profit $1,977,313 $457,518 332%

Gross Profit Margin 30% 15%

Net Income $1,283,683 $131,736 874%

Net Income Margin 20% 4%

Earnings Per Share $0.07 $0.01 600%

Huifeng achieved outstanding growth during 2007, with sales more than doubling and net income increasing by over 800%. "Huifeng achieved a number of significant milestones in 2007. We have increased our product offering and achieved significant sales in both Rutin and Diosmin," states company CEO Jing'An Wang. Furthermore, in late 2007, Huifeng signed the largest supply agreement in company history and completed a $2 million fundraising.

"Huifeng expects to continue achieving significant gains in both sales and net income in 2008 through organic growth of our current products," forecasted Mr. Wang. The company restructured its production lines in the fourth quarter to accommodate the increased production levels of Diosmin necessitated under its current contract with Safic-Alcan of France. Huifeng also hopes to close a strategic acquisition in 2008 under its sta
'/>"/>

SOURCE Huifeng Bio-Pharmaceutical Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
2. Skystar Bio-Pharmaceutical Raises 2007 Revenue Guidance to $15.8 Million
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... -- Dublin ... the addition of the  "Micro Market Monitor : ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,The ... segments in the chromatography market. The market was ... to reach $2.0 billion by 2019, at a ...
(Date:9/18/2014)... 18, 2014 HealthTronics, Inc ... interventional radiology products and services, announced that a ... and cryoablation) versus external beam radiotherapy (EBRT) is ... American Urological Association (MAAUA) Annual Meeting in Baltimore, ... Effectiveness of Cryosurgery and External Beam Radiation as ...
(Date:9/18/2014)... KEEGO HARBOR, Mich. , Sept. 18, 2014  Health ... -based biotech firm investigating early-stage algae bioactive compounds and metabolic ... member to the company,s board of directors. Ms. Nola ... executive and investment advisor joined the board effective September 17, ... have Ms. Masterson agree to join our board," states ...
(Date:9/18/2014)... Sept. 18, 2014 Research and Markets ... and Chinese Stem Cell Industry Report, 2014-2017" report ... undifferentiated biological cells that can differentiate into specialized cells ... cells. Stem cell therapy can be applied to treatment ... disease), nervous system diseases, damage or lesion of liver, ...
Breaking Biology Technology:Micro Market Monitor : Global Pre-packed Chromatography Columns 2HealthTronics Announces Data Comparing Cryotherapy Versus Radiation for Treating Prostate Cancer Poster Presented at the American Urological Association Regional Meeting 2Health Enhancement Announces New Board Member In Advance Of Annual Shareholder Meeting 2Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3
... Omega Protein Corporation (NYSE symbol: OME), a nutritional ... fish oil and specialty fish meal products, today announced ... strategic advisor in connection with its omega-3 fish oil ... Lipid Technologies is an analytical services and biotechnology consulting ...
... a diagnostic company focused on breath analysis for the ... a Small Business Innovation Research (SBIR) contract by the ... I/II Fast-Track contract will support the research and development ... Metabolomx, proprietary technology is designed to recognize ...
... October 24, 2011 Silence Therapeutics ... (RNAi) therapeutics company, today announced that it has ... ("Mirna"), a biopharmaceutical company pioneering microRNA-based therapeutics for ... proprietary AtuPLEX™ and DBTC delivery systems for Mirna,s ...
Cached Biology Technology:Omega Protein Announces Retention of Lipid Technologies, LLC 2Metabolomx Awarded $1.14 Million SBIR Grant from National Cancer Institute for Breath Analysis Test of Lung Cancer 2Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics 2Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics 3Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics 4Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics 5Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics 6
(Date:9/18/2014)... 18, 2014Many Americans across racial and ethnic groups ... impact on their day-to-day life, more so than ... and speech (57% of African-Americans, 49% of non-Hispanic ... When asked which disease or ailment is the ... first among African-Americans followed by AIDS/HIV. Hispanics ...
(Date:9/18/2014)... in the eastern Mediterranean Sea pose a major threat ... to expand as the climate warms, a new study ... led by Dr Adriana Vergs of UNSW Australia and ... Studies in Spain, is published in the Journal ... than 1000 kilometres of coastline in Turkey and Greece, ...
(Date:9/18/2014)... too stressed they are often grouchy, grumpy, nasty, distracted ... at EPFL have just highlighted a fundamental synaptic mechanism ... loss of social skills and cognitive impairment. When triggered ... in the brain. This was revealed by a work ... Sandi,s team went to look for answers in a ...
Breaking Biology News(10 mins):Americans rate losing eyesight as having greatest impact on their lives 2Americans rate losing eyesight as having greatest impact on their lives 3Tropical fish a threat to Mediterranean Sea ecosystems 2How stress tears us apart 2
... that several herbicides used on corn also have good ... a potential bioenergy feedstock. "No herbicides are currently ... said Eric Anderson, an instructor of bioenergy for the ... Illinois. "Our research shows that several herbicides used on ...
... RIVERSIDE, Calif. Geologists at the University of California, ... indicates that Earth,s ancient oceans were oxygen-free and, surprisingly, ... are the first to show that ample hydrogen sulfide ... history," said Timothy Lyons , a professor of ...
... The 1st IOF-ESCEO Pre-Clinical Symposium, a new forum for ... to be held from March 22-23, 2011, immediately preceding ... Valencia. The Symposium will be chaired by Gerard Karsenty, ... one of the world,s leading scientists from the ...
Cached Biology News:Miscanthus has a fighting chance against weeds 2Oxygen-free early oceans likely delayed rise of life on planet 2Oxygen-free early oceans likely delayed rise of life on planet 3